menu
    • menu

    Company profile for Anova Enterprises

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Anova has designed a new approach to conducting clinical trials. Our AnovaOS™ platform shaves years off the time to bring new investigational products to market, reduces product development cost, improves patient access to investigational treatments and facilitates a move to a patient-focused development approach grounded in precision medicine.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Anova EnterprisesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1 Arlington Executive Center 3400 West Stonegate Boulevard Suite 101 Arlington...
    Telephone
    Telephone
    +1 (224) 218-2408
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://anovaevidence.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/anovaevidence/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Anova Launches AI to Speed Clinical Trials Enrollment
    Anova Launches AI to Speed Clinical Trials Enrollment

    16 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/anova-launches-ai-powered-patient-matching-platform-to-speed-clinical-trial-enrollment-18576

    INDPHARMAPOST
    16 Dec 2025
    Share Share
    Anova Launches Free AI-enabled Clinical Trial Patient
    Anova Launches Free AI-enabled Clinical Trial Patient

    12 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251212784032/en/Anova-Launches-Free-AI-enabled-Clinical-Trial-Patient-Matching-Solution-as-Part-of-a-Global-Just-in-time-Research-Network

    BUSINESSWIRE
    12 Dec 2025
    Share Share
    Anova Initiates Global Clinical Registry For Rapid New Treatment
    Anova Initiates Global Clinical Registry For Rapid New Treatment

    23 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250923082433/en/Anova-Launches-Global-Clinical-Registry-to-Accelerate-Research-and-Access-to-Promising-New-Treatments

    BUSINESSWIRE
    23 Sep 2025
    Share Share
    Anova Expands Leadership Team To Drive Growth And Innovation
    Anova Expands Leadership Team To Drive Growth And Innovation

    29 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250129612183/en

    BUSINESSWIRE
    29 Jan 2025
    Share Share
    Anova to Manage Study of DB107 Following Newly Awarded $11.8M CIRM Grant
    Anova to Manage Study of DB107 Following Newly Awarded $11.8M CIRM Grant

    01 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240430585754/en

    BUSINESSWIRE
    01 May 2024
    Share Share
    FDA Authorizes Phase 2 of DB107 In Promising Turn-Around of Targeted Treatment
    FDA Authorizes Phase 2 of DB107 In Promising Turn-Around of Targeted Treatment

    25 Jul 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230725732987/en

    BUSINESSWIRE
    25 Jul 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search